NEW YORK (GenomeWeb News) – Cepheid reported on Thursday afternoon that its first-quarter revenue fell 13 percent year over year, largely due to a 45 percent drop in system sales.

The firm brought in revenues of $38.8 million for the three-month period ended March 31, compared to revenues of $44.8 million in the first quarter of 2008.

System sales dropped to $7.9 million from $14.3 million year over year, while sales of reagents and disposables increased 4 percent to $28.7 million from $27.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.